- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
**Financial Performance:** For H1 FY25, Pokarna Limited reported total revenue of ₹450.80 crore, a growth of 22.47% year-over-year. EBITDA was ₹154.10 crore (up 26.55%), EBIT reached ₹132.22 crore (increasing by 31.04%), while PAT surged by 54.18% to ₹78.05 crore, leading to an EPS of ₹25.17. In Q2 FY25, revenue was ₹253.46 crore, marking a 24.33% increase, with EBITDA at ₹88.29 crore (20.67% growth), EBIT at ₹77.76 crore (22.44% growth), and PAT at ₹44.96 crore (up 37.49%), translating to an EPS of ₹14.50.
**Future Outlook and Growth Drivers:** Management expressed optimism about U.S. market stabilization, supported by Federal Reserve rate cuts, which may drive remodeling projects. Strategic growth will focus on launching new quartz products, expanding marketing efforts, and enhancing operational efficiencies.
**Order Book and Operational Updates:** The company plans a major investment of ₹440 crore to expand its Mekaguda facility, adding a third Bretonstone production line aimed for operational status by March 2026. Technological advancements include the upcoming KREOS and Chromia lines expected to launch in Q4 FY25.
**Analyst Q&A Insights:** Analysts probed various aspects, including revenue projections from the new capacity. Management indicated potential revenue of ₹450 to 525 crore when fully operational, although such expectations are contingent upon market conditions. Clarifying U.S. demand, they acknowledged a stabilizing yet cautious outlook. On cost pressures, management noted a normalization of freight rates and margins sustained around 35%.
**Market or Regulatory Updates:** There are no significant regulatory changes impacting the business, with an ongoing focus on managing competitive pricing pressures.
**Strategic Focus Areas:** The emphasis on innovation, product differentiation, and market expansion into promising areas like Canada and France remains key, balancing against cautious expectations for the U.S. market.
**Investor Insight:** Given robust financial health, growth potential aligned with market strategies, and management’s proven track record, a 'buy' position appears favorable, contingent on effective execution of the outlined strategies and ability to navigate market uncertainties.